Relaxo Footwears just reported Q1 2027 results, with both revenue and net profit higher than in Q1 2026 and a slightly thicker net margin, yet that recent progress sits awkwardly beside what long term holders have actually lived through. Investors who held Relaxo Footwears over the past year are down 31.5%, including dividends. If you had locked in a position back on 16 October 2025, how should this gap between improving metrics and a weak share outcome shape expectations for what comes next?
A Narrative on Simply Wall St is one investor's written case for a company, with its growth, margin and multiple assumptions spelled out. Those assumptions imply an estimated Fair Value.
If the move has made Relaxo Footwears harder to judge, start where the gap is still open and scan 191 high quality undervalued stocks .
The Argument Relaxo Footwears Investors Were Weighing Up
The shares cost ₹440 at the start of the period, and anyone looking at Relaxo Footwears then had two very different stories on the table that both sounded plausible.
The bullish narrative put Fair Value at ₹477. It leaned on data driven retail expansion and premium footwear, plus in-house efficiencies, aiming for better margins and higher quality revenue through tools like the Relaxo Parivaar app and a tighter distribution model.
The bearish view set Fair Value at ₹385. It focused on reliance on low priced footwear, stalled e-commerce at roughly 10% of sales, and rising digital competition as meaningful threats to future earnings stability.
What The Results Changed For Relaxo Footwears
The clearest new fact was Q1 2027 trading. Relaxo Footwears reported revenue of ₹7,050.5m and net income of ₹549.4m, up from ₹6,544.9m and ₹489m in Q1 2026, with net margin edging from 7.5% to 7.8%. That shift in profitability supported the view that higher quality sales and efficiencies could lift earnings, although only modestly so far.
The key takeaway is simple. When a story leans on better economics per unit, check whether net margin, not just revenue or profit, is actually moving in the direction the narrative relies on.
What Relaxo Footwears Buyers Are Being Asked To Believe Now
Relaxo Footwears now trades at ₹297 after a 31.5% loss over the past year. The selected Narrative still places its Fair Value above that level and ties that view to tax changes, premium ranges and channel reach rather than just a simple rebound story.
For the recent fall to look like an opening instead of a warning, a buyer today would need to believe Relaxo can execute premiumization, keep volume growth intact and lift margins as the Narrative suggests.
"GST 2.0 has lowered tax on footwear below ₹2,500 to 5% for more than 98% of Relaxo Footwears portfolio, which could allow the company to widen its reach into price sensitive mass and mid market buyers and support higher revenue over time as formal players take share from unorganized competitors."
One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all
Looking Beyond Relaxo Footwears
Relaxo Footwears is pushing further into branded, higher quality footwear. You could also look at what scale already looks like.
One global sportswear giant reaches that scale through a strong athletic focus. Its presence lets design, marketing and production costs stretch across many buyers.
That structure keeps prices relatively accessible for middle and lower income shoppers. It still tries to protect profitability through tight cost control.
Some investors compare that model with Relaxo's mass plus premium mix. The unresolved point is how much value you place on sheer global reach.
That argument has a Narrative and a number behind it. → See the company one Narrative values 16% above its price
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include 530517.bse .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
